- -- Quick Links --
-
- Home
- The focus
- Organizers
- FABA
- Pharmexcil
- Industry Speak
- BioAsia 2012
- BioAsia 2011
- BioAsia 2010
- BioAsia 2009
- Proceedings 2012
- Proceedings 2011
- Proceedings 2010
- Proceedings 2009
- Awards-2012
- Awards-2011
- Awards-2010
- Awards-2009
- Photo Gallery 2012
- Photo Gallery 2011
- Photo Gallery 2010
- Photo Gallery 2009
- Video Gallery 2012
- Video Gallery 2011
- Presentation
- Publications
- Contact Us
About BioAsia
Focus
Biotechnology being an emerging industry, game-changing strategies and relevant application of the knowledge-intelligence resource pool, drive the process of growth. BioAsia seeks to enhance, enrich and encourage newer innovations, path-breaking discoveries and effective solutions in the industry by offering a vibrant global platform for convergence of the key stakeholders - Biotech & Biopharma Companies, research institutions, investors, service providers, policy makers, regulators and analysts.
Organizers
Genome Valley
Genome Valley, spread over 600 sq. kms. in the vicinity of Hyderabad (the Cyber City of India) is India's first world-class biotech cluster for biotech research, training, collaboration and manufacturing activities. With an established presence of several global and Indian biotechnology companies, globally renowned research institutions, and best-in-class supporting specialized infrastructure, today Genome Valley is the largest and most vibrant biotech cluster in the country...
Industry Speak
Dr. Seth Berkley, CEO, GAVI Alliance
India is a prime example of how the vaccine landscape has changed over the past 20 years....
Dr. Krishna M. Ella, CMD, Bharat Biotech International Ltd., Hyderabad
Dr. K V Balasubramaniam, Managing Director, Indian Immunologicals Ltd.
More professionally conducted this time with better industry participation
Dr. Krishna M. Ella, CMD, Bharat Biotech International Ltd., Hyderabad
Vishal Gandhi, SVP and Head- Life Sciences, Yes Bank
Roopesh Bhargava, Director - Sales & Marketing, Sanofi Pasteur India (Pvt) Ltd., Mumbai
Dr. Shreemanta K Parida, CEO, Vaccine Grand Challenge Program, Dept of Biotechnology, Ministry of Science & Technology, Govt. of India
Dr. Harish Iyer, CEO, Shantha Biotech, Hyderabad
Mr. Manni Kantipudi, Chief Executive Officer, GVK Biosciences
Dr. K V Balasubramaniam, Managing Director, Indian Immunologicals Ltd.
"More professionally conducted this time with better industry participation"